NCT00056810View on ClinicalTrials.gov

Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

May 31, 2005

Conditions
Guillain-Barre Syndrome
Interventions
DRUG

4-aminopyridine (4-AP)

Trial Locations (1)

48201-2417

Rehabilitation Institute of Michigan at Detroit Medical Center, Detroit

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00056810 - Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine | Biotech Hunter | Biotech Hunter